(A) Scheme representing the prophylactic vaccine protocol against VL. All mice groups were infected; PBS group represents non-vaccinated mice, ID LdAg group represents intradermally vaccinated mice and IN LdAg represents intranasally vaccinated mice. Mouse image is from smart.servier.com. (B, C) Spleen (B) and liver (C) weights measured immediately after dissection of different mice groups. (D-F) The effect of ID and IN LdAg vaccine on L. donovani parasite count in livers (D), spleens (E) and bone marrows (F) estimated by qPCR in 75 ng of tissue gDNA. Data are representative of two independent experiments and are presented as means ± SEM (n = 5–7; one-way ANOVA).</p
<p><i>Leishmania</i> parasite burden (number. of amastigotes per 1000 cell nuclei) in the dab smears...
<p>Parasite loads of liver, spleen, and bone marrow in murine model of established visceral leishman...
BACKGROUND: The development of cost-effective prophylactic strategies to prevent leishmaniasis has b...
<p>Mice were either vaccinated with SLA-pulsed, SLA+ CpG-ODN pulsed, SLA+ control-CpG-ODN pulsed, on...
After our promising results from prophylactic and therapeutic study (i.p. route) with the radio-atte...
Leishmaniasis is a disease caused by an intracellular protozoan parasite of the genus Leishmania. Cu...
<p><strong><em>Background:</em></strong> Currently, there is no vaccine available for any form of le...
Gp63 is a major surface protein of Leishmania promastigotes. Its protective efficacy has been tested...
A soluble cocktail vaccine was prepared from sonicated promastigotes of five Iraqi Leishmania i...
The prophylactic efficacy of autoclaved Leishmania donovani (ALD) and autoclaved L. major (ALM) – a ...
Our previous studies in BALB/c mice showed substantial protection against the experimental murine vi...
Leishmanial antigens (LAg) were used as a vaccine against Leishmania donovani, the causative agent o...
Background: New strategies for control of leishmaniasis is needed as chemotherapy usingantimonial dr...
In this work, the effect of vaccination of a newly described Leishmania infantum antigenic protein h...
AbstractLeishmania lipophosphoglycan (LPG) is a molecule that has been used as a vaccine candidate, ...
<p><i>Leishmania</i> parasite burden (number. of amastigotes per 1000 cell nuclei) in the dab smears...
<p>Parasite loads of liver, spleen, and bone marrow in murine model of established visceral leishman...
BACKGROUND: The development of cost-effective prophylactic strategies to prevent leishmaniasis has b...
<p>Mice were either vaccinated with SLA-pulsed, SLA+ CpG-ODN pulsed, SLA+ control-CpG-ODN pulsed, on...
After our promising results from prophylactic and therapeutic study (i.p. route) with the radio-atte...
Leishmaniasis is a disease caused by an intracellular protozoan parasite of the genus Leishmania. Cu...
<p><strong><em>Background:</em></strong> Currently, there is no vaccine available for any form of le...
Gp63 is a major surface protein of Leishmania promastigotes. Its protective efficacy has been tested...
A soluble cocktail vaccine was prepared from sonicated promastigotes of five Iraqi Leishmania i...
The prophylactic efficacy of autoclaved Leishmania donovani (ALD) and autoclaved L. major (ALM) – a ...
Our previous studies in BALB/c mice showed substantial protection against the experimental murine vi...
Leishmanial antigens (LAg) were used as a vaccine against Leishmania donovani, the causative agent o...
Background: New strategies for control of leishmaniasis is needed as chemotherapy usingantimonial dr...
In this work, the effect of vaccination of a newly described Leishmania infantum antigenic protein h...
AbstractLeishmania lipophosphoglycan (LPG) is a molecule that has been used as a vaccine candidate, ...
<p><i>Leishmania</i> parasite burden (number. of amastigotes per 1000 cell nuclei) in the dab smears...
<p>Parasite loads of liver, spleen, and bone marrow in murine model of established visceral leishman...
BACKGROUND: The development of cost-effective prophylactic strategies to prevent leishmaniasis has b...